← European Medicine Shortage Tracker · all medicines
Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.
Roxithromycine currently has availability issues reported in 2 European registers: France, Italy.
Shortage ATC — · also listed as: roxithromycine · ROXITROMICINA · data refreshed 9 September 2026
As of 9 September 2026, 2 of the 9 tracked registers list current availability issues for Roxithromycine, covering 4 affected product presentations. The longest-running open report was filed in Italy on 2026-03-31 and has now been open for about 6 months. Where agencies state a cause, commercial decisions or discontinuation lead with 1 of the 1 stated-cause reports. The furthest expected-resolution date currently on file is 2026-10-31; the earliest is 2026-10-31. Momentum is current, not historical: 2 of the open reports were filed within the last 90 days. Registers in Italy indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching.
| Where | Status & products | Since | Expected end | Reason / alternatives | Source |
|---|---|---|---|---|---|
| 🇫🇷 France | Limited availability Spécialités à base de roxithromycine 150 mg, comprimé pelliculé | — | — | Infectiologie | register ↗ |
| 🇮🇹 Italy | Shortage ASSORAL + 2 more productsRULID RULID | 2026-03-31 | 2026-10-31 | Cessata commercializzazione temporanea Alternatives: AIFA: equivalents with the same active substance are available. | register ↗ |
Every individual register entry for Roxithromycine in the tracked sources, newest first — including resolved and discontinued reports.
| Reg. | Product | Status | Reported | Expected end | Stated reason |
|---|---|---|---|---|---|
| 🇮🇹 IT | RULID | Shortage | 2026-09-30 | 2026-10-31 | Problemi regolatori |
| 🇮🇹 IT | RULID | Shortage | 2026-08-31 | 2026-10-31 | Problemi regolatori |
| 🇮🇹 IT | ASSORAL | Shortage | 2026-03-31 | — | Cessata commercializzazione temporanea |
| 🇫🇷 FR | Spécialités à base de roxithromycine 150 mg, comprimé pelliculé | Limited availability | — | — | Infectiologie |
Yes. As of 9 September 2026, availability issues are reported in: France, Italy. Availability is national — a shortage in one country does not mean it is short everywhere.
Agency prognoses on file range from 2026-10-31 to 2026-10-31. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.
3 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.
Directly from the official medicines-agency registers that list Roxithromycine: ANSM (France), AIFA (Italy). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.
Pharmacies, patient sites and newsrooms are welcome to embed the live status of Roxithromycine — free, with attribution. Copy this snippet:
<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/roxithromycine/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Roxithromycine availability in Europe"></iframe> <p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/roxithromycine/">Roxithromycine shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>